Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methsuximide reduces valproic acid serum levels.

F M Besag1, D J Berry, M Vasey

  • 1St Piers Lingfield, (Now The National Centre for Young People With Epilepsy) Surrey, England, UK. FBesag@aol.com

Therapeutic Drug Monitoring
|January 22, 2002
PubMed
Summary

Methsuximide significantly reduces serum valproic acid levels in patients. This drug interaction necessitates dose adjustments of valproate to maintain therapeutic efficacy and prevent toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigenda.

The bone & joint journal·2020
Same author

Prior hip or knee prosthetic joint infection in another joint increases risk three-fold of prosthetic joint infection after primary total knee arthroplasty: a matched control study.

The bone & joint journal·2019
Same author

2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis.

The bone & joint journal·2019
Same author

Lumbar fusion involving the sacrum increases dislocation risk in primary total hip arthroplasty.

The bone & joint journal·2019
Same author

Irrigation and debridement with chronic antibiotic suppression for the management of infected total knee arthroplasty: A Contemporary Analysis.

The bone & joint journal·2018
Same author

The use of highly crosslinked polyethylene in total knee arthroplasty.

The bone & joint journal·2017

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Neurology

Background:

  • Valproic acid is a widely used antiepileptic drug.
  • Methsuximide is another antiepileptic medication.
  • Potential drug interactions between antiepileptic drugs require investigation.

Purpose of the Study:

  • To determine the effect of methsuximide on serum valproic acid levels.
  • To assess the clinical implications of this drug interaction.

Main Methods:

  • Serum valproic acid levels were measured in 17 patients (aged 8-19 years).
  • Measurements were taken before and during methsuximide treatment, or after stopping methsuximide.
  • Valproate and other medication doses remained constant during the study.

Related Experiment Videos

Main Results:

  • Mean serum valproic acid levels decreased significantly (p < 0.001) when patients took methsuximide.
  • When methsuximide was initiated, valproic acid levels dropped from 85.4 to 58.2 mg/L.
  • When methsuximide was stopped, valproic acid levels increased significantly (p = 0.025) from 49.8 to 71.7 mg/L.

Conclusions:

  • Methsuximide significantly lowers serum valproic acid concentrations.
  • Clinicians should consider adjusting valproate dosage when initiating or discontinuing methsuximide.
  • Monitoring valproic acid levels is crucial to avoid subtherapeutic levels or toxicity.